DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 127 filers reported holding DYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,511,180 | -49.4% | 478,401 | -49.1% | 0.10% | -57.4% |
| Q4 2022 | $10,890,520 | -14.2% | 939,648 | -6.0% | 0.23% | -31.1% |
| Q3 2022 | $12,700,000 | +84.9% | 1,000,000 | 0.0% | 0.33% | +127.2% |
| Q2 2022 | $6,870,000 | -28.7% | 1,000,000 | 0.0% | 0.15% | -26.9% |
| Q1 2022 | $9,640,000 | -18.9% | 1,000,000 | 0.0% | 0.20% | +9.2% |
| Q4 2021 | $11,890,000 | -26.8% | 1,000,000 | 0.0% | 0.18% | -13.2% |
| Q3 2021 | $16,240,000 | -22.8% | 1,000,000 | 0.0% | 0.21% | -2.3% |
| Q2 2021 | $21,040,000 | +35.5% | 1,000,000 | 0.0% | 0.22% | +41.8% |
| Q1 2021 | $15,530,000 | +23.3% | 1,000,000 | +66.7% | 0.15% | +53.0% |
| Q4 2020 | $12,600,000 | +4.0% | 600,000 | 0.0% | 0.10% | +8.7% |
| Q3 2020 | $12,114,000 | – | 600,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $104,175,000 | 19.37% |
| Vida Ventures Advisors, LLC | 2,960,046 | $62,280,000 | 15.62% |
| Logos Global Management LP | 2,054,392 | $43,224,000 | 3.63% |
| GREAT POINT PARTNERS LLC | 672,559 | $14,151,000 | 2.97% |
| Octagon Capital Advisors LP | 583,649 | $12,280,000 | 2.54% |
| COMMODORE CAPITAL LP | 305,125 | $6,420,000 | 2.24% |
| RA Capital Management | 2,805,045 | $59,018,000 | 0.95% |
| Altium Capital Management LP | 166,636 | $3,506,000 | 0.81% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 135,000 | $2,840,000 | 0.75% |
| Soleus Capital Management, L.P. | 178,360 | $3,753,000 | 0.58% |